The	O
interleukin	B-DNA
2	I-DNA
receptor	I-DNA
alpha	I-DNA
chain/CD25	I-DNA
promoter	I-DNA
is	O
a	O
target	O
for	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
.	O

The	O
expression	O
of	O
the	O
murine	B-protein
interleukin	I-protein
(	I-protein
IL	I-protein
)	I-protein
-2	I-protein
receptor	I-protein
alpha	I-protein
chain/CD25	I-protein
is	O
strongly	O
induced	O
at	O
the	O
transcriptional	O
level	O
after	O
T	O
cell	O
activation	O
.	O

We	O
show	O
here	O
that	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cell	I-protein
(	I-protein
NF-AT	I-protein
)	I-protein
factors	I-protein
are	O
involved	O
in	O
the	O
control	O
of	O
CD25	B-DNA
promoter	I-DNA
induction	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

NF-ATp	B-protein
and	O
NF-ATc	B-protein
bind	O
to	O
two	O
sites	O
around	O
positions	B-DNA
-585	I-DNA
and	I-DNA
-650	I-DNA
located	O
upstream	O
of	O
the	O
proximal	B-DNA
CD25	I-DNA
promoter	I-DNA
.	O

Immediately	O
3	O
'	O
from	O
these	O
NF-AT	B-DNA
motifs	I-DNA
,	O
nonconsensus	B-DNA
sites	I-DNA
are	O
located	O
for	O
the	O
binding	O
of	O
AP-1-like	B-protein
factors	I-protein
.	O

Mutations	O
of	O
sites	O
that	O
suppress	O
NF-AT	B-protein
binding	O
impair	O
the	O
induction	O
and	O
strong	O
NF-ATp	B-protein
-mediated	O
transactivation	O
of	O
the	O
CD25	B-DNA
promoter	I-DNA
in	O
T	B-cell_type
cells	I-cell_type
.	O

In	O
T	B-cell_type
lymphocytes	I-cell_type
from	O
NF-ATp	B-protein
-deficient	O
mice	O
,	O
the	O
expression	O
of	O
CD25	B-protein
is	O
severely	O
impaired	O
,	O
leading	O
to	O
a	O
delayed	O
IL-2	B-protein
receptor	I-protein
expression	O
after	O
T	O
cell	O
receptor	O
(	O
TCR	B-protein
)	O
/	O
CD3	B-protein
stimulation	O
.	O

Our	O
data	O
indicate	O
an	O
important	O
role	O
for	O
NF-AT	B-protein
in	O
the	O
faithful	O
expression	O
of	O
high	B-protein
affinity	I-protein
IL-2	I-protein
receptors	I-protein
and	O
a	O
close	O
link	O
between	O
the	O
TCR	B-protein
-mediated	O
induction	O
of	O
IL-2	B-protein
and	O
IL-2	B-DNA
receptor	I-DNA
alpha	I-DNA
chain	I-DNA
promoters	I-DNA
,	O
both	O
of	O
which	O
are	O
regulated	O
by	O
NF-AT	B-protein
factors	I-protein
.	O

Brief	NULL
Definitive	NULL
Report	NULL
The	NULL
Interleukin	NULL
2	NULL
Receptor	NULL
a	NULL
Chain/	NULL
CD25	NULL
Promoter	NULL
Is	NULL
a	NULL
Target	NULL
for	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
By	NULL
Kai	NULL
Schuh	NULL
,	NULL
*	NULL
ThomasTwardzik	NULL
,	NULL
*	NULL
Burkhard	NULL
Kneitz	NULL
,	NULL
*	NULL
Jorg	NULL
Heyer	NULL
,	NULL
*	NULL
Anneliese	NULL
Schimpl	NULL
,	NULL
*	NULL
and	NULL
Edgar	NULL
Serfling*	NULL
From	NULL
the	NULL
*	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
and	NULL
the	NULL
*Institute	NULL
of	NULL
V	NULL
irology	NULL
and	NULL
Immunobiology	NULL
,	NULL
University	NULL
of	NULL
Wiir	NULL
burg	NULL
D-97080	NULL
W	NULL
iirz	NULL
burg	NULL
Germany	NULL
Sum	NULL
m	NULL
ary	NULL
The	NULL
expression	NULL
of	NULL
the	NULL
murine	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2	NULL
receptor	NULL
«	NULL
chain/	NULL
CD25	NULL
is	NULL
strongly	NULL
induced	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
(	NULL
NF-AT	NULL
)	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
CD25	NULL
promoter	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
NFAT	NULL
p	NULL
and	NULL
NF-AT	NULL
e	NULL
bind	NULL
to	NULL
two	NULL
sites	NULL
around	NULL
positions	NULL
-585	NULL
and	NULL
-650	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
proximal	NULL
CD25	NULL
promoter	NULL
.	NULL

Immediately	NULL
3	NULL
'	NULL
from	NULL
these	NULL
NF-AT	NULL
motifs	NULL
,	NULL
nonconsensus	NULL
sites	NULL
are	NULL
located	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
AP-	NULL
1-like	NULL
factors	NULL
.	NULL

Mutations	NULL
of	NULL
sites	NULL
that	NULL
suppress	NULL
NF-AT	NULL
binding	NULL
impair	NULL
the	NULL
induction	NULL
and	NULL
strong	NULL
NF-	NULL
AT	NULL
p-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
CD25	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
from	NULL
NF-ATp-deficient	NULL
mice	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD25	NULL
is	NULL
severely	NULL
impaired	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
delayed	NULL
IL-2	NULL
receptor	NULL
expression	NULL
after	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
CD3	NULL
stim-ulation	NULL
.	NULL

O	NULL
ur	NULL
data	NULL
indicate	NULL
an	NULL
important	NULL
role	NULL
for	NULL
NF-AT	NULL
in	NULL
the	NULL
faithful	NULL
expression	NULL
of	NULL
high	NULL
affinity	NULL
IL-2	NULL
receptors	NULL
and	NULL
a	NULL
close	NULL
link	NULL
between	NULL
the	NULL
TCR	NULL
-mediated	NULL
induction	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2	NULL
re	NULL
ceptor	NULL
«	NULL
chain	NULL
promoters	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
regulated	NULL
by	NULL
NF-	NULL
AT	NULL
factors	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
T	NULL
cells	NULL
«	NULL
NF-AT	NULL
factors	NULL
he	NULL
high	NULL
affinity	NULL
IL-2	NULL
receptor	NULL
consists	NULL
of	NULL
three	NULL
individ-	NULL
ual	NULL
polypeptides	NULL
,	NULL
the	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
chains	NULL
.	NULL

Although	NULL
the	NULL
B	NULL
and	NULL
y	NULL
chains	NULL
are	NULL
shared	NULL
by	NULL
other	NULL
lymphokine	NULL
receptors	NULL
,	NULL
the	NULL
«	NULL
chain	NULL
(	NULL
CD25	NULL
)	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
IL-2	NULL
receptor	NULL
,	NULL
and	NULL
is	NULL
expressed	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
lymphoid	NULL
cells	NULL
(	NULL
for	NULL
review	NULL
see	NULL
reference	NULL
1	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
CD25	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
controlled	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
through	NULL
two	NULL
DN	NULL
A	NULL
sequence	NULL
ele-ments	NULL
,	NULL
a	NULL
proximal	NULL
promoter/	NULL
enhancer	NULL
spanning	NULL
the	NULL
nucleotides	NULL
between	NULL
positions	NULL
-54	NULL
and	NULL
-584	NULL
in	NULL
the	NULL
mouse	NULL
and	NULL
-64	NULL
and	NULL
-276	NULL
in	NULL
humans	NULL
,	NULL
and	NULL
a	NULL
distal	NULL
enhancer	NULL
spanning	NULL
~80	NULL
nucleotides	NULL
around	NULL
position	NULL
-1350	NULL
in	NULL
the	NULL
mouse	NULL
and	NULL
-3750	NULL
(	NULL
or	NULL
-4150	NULL
,	NULL
according	NULL
to	NULL
another	NULL
nomenclature	NULL
)	NULL
in	NULL
the	NULL
human	NULL
CD25	NULL
gene	NULL
(	NULL
2-6	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
TCR	NULL
-mediated	NULL
signals	NULL
or	NULL
IL-1	NULL
,	NULL
and	NULL
is	NULL
controlled	NULL
by	NULL
an	NULL
array	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
in	NULL
particular	NULL
by	NULL
nuclear	NULL
factor	NULL
Elf-1	NULL
,	NULL
SRF	NULL
,	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
is	NULL
controlled	NULL
by	NULL
IL-2	NULL
,	NULL
which	NULL
induces	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
5	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
family	NULL
of	NULL
Stat	NULL
transcription	NULL
factors	NULL
.	NULL

Stat5	NULL
binds	NULL
in	NULL
concert	NULL
with	NULL
Elf-	NULL
1	NULL
,	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
GATA	NULL
factors	NULL
to	NULL
multiple	NULL
sites	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
and	NULL
The	NULL
first	NULL
two	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
paper	NULL
.	NULL

1369	NULL
interleukin	NULL
2	NULL
receptor	NULL
*	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
*	NULL
transcription	NULL
factors	NULL
®	NULL
contributes	NULL
to	NULL
its	NULL
IL-2-mediated	NULL
full	NULL
expression	NULL
in	NULL
activated	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
(	NULL
NF-AT	NULL
)	NULL
factors	NULL
comprise	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
numerous	NULL
lymphokine	NULL
and	NULL
receptor	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
Similar	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
,	NULL
the	NULL
nuclear	NULL
translocation	NULL
and	NULL
activity	NULL
of	NULL
NF-AT	NULL
factors	NULL
is	NULL
stimulated	NULL
by	NULL
TCR	NULL
-mediated	NULL
signals	NULL
(	NULL
for	NULL
review	NULL
see	NULL
reference	NULL
7	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
domains	NULL
of	NULL
NF-AT	NULL
and	NULL
R	NULL
el	NULL
factors	NULL
share	NULL
a	NULL
common	NULL
architecture	NULL
(	NULL
8	NULL
)	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
recognize	NULL
overlapping	NULL
DNA	NULL
sequence	NULL
motifs	NULL
These	NULL
common	NULL
properties	NULL
between	NULL
NF-AT	NULL
and	NULL
NF-KB	NULL
(	NULL
a	NULL
major	NULL
regulator	NULL
of	NULL
the	NULL
CD25	NULL
promoter	NULL
)	NULL
,	NULL
and	NULL
reports	NULL
on	NULL
the	NULL
inhibition	NULL
of	NULL
CD25	NULL
expression	NULL
by	NULL
cyclosporin	NULL
A	NULL
(	NULL
9	NULL
)	NULL
(	NULL
an	NULL
inhibitor	NULL
of	NULL
phos-phatase	NULL
calcineurin	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
of	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
AT	NULL
;	NULL
reference	NULL
7	NULL
)	NULL
,	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
NF-	NULL
AT	NULL
factors	NULL
participate	NULL
in	NULL
CD25	NULL
promoter	NULL
control	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
NF-AT	NULL
p	NULL
and	NULL
NF-ATe	NULL
bind	NULL
to	NULL
two	NULL
sites	NULL
located	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
proximal	NULL
CD25	NULL
promoter	NULL
.	NULL

Mutations	NULL
within	NULL
the	NULL
NF-AT	NULL
sites	NULL
that	NULL
suppress	NULL
NF-AT	NULL
binding	NULL
impair	NULL
CD25	NULL
promoter	NULL
induction	NULL
.	NULL

Ac-cordingly	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
CD25	NULL
is	NULL
markedly	NULL
delayed	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
NF-AT	NULL
p-deficient	NULL
mice	NULL
.	NULL

These	NULL
findings	NULL
implicate	NULL
an	NULL
important	NULL
role	NULL
for	NULL
NF-AT	NULL
factors	NULL
in	NULL
the	NULL
inducible	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/	NULL
98/	NULL
10/	NULL
1369/05	NULL
$	NULL
2.00	NULL
Volume	NULL
188	NULL
,	NULL
Number	NULL
7	NULL
,	NULL
October	NULL
5	NULL
,	NULL
1998	NULL
1369-1373	NULL
http	NULL
:	NULL
//	NULL
www.jem.org	NULL
expression	NULL
of	NULL
high	NULL
affinity	NULL
IL-2	NULL
receptors	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
,	NULL
Construction	NULL
,	NULL
and	NULL
T	NULL
rnsfection	NULL
of	NULL
CD25	NULL
Promoter	NULL
Lu-dferase	NULL
Plasmids	NULL
.	NULL

_	NULL
Murine	NULL
E4	NULL
T	NULL
thymoma	NULL
cells	NULL
and	NULL
human	NULL
Jurkat	NULL
T	NULL
leukemia	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
FCS	NULL
.	NULL

2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
DEAE	NULL
dextran	NULL
protocol	NULL
with	NULL
2.5	NULL
ug	NULL
DNA	NULL
of	NULL
the	NULL
CD25	NULL
promoter-luciferase	NULL
reporter	NULL
constructs	NULL
alone	NULL
or	NULL
0.5-2.5	NULL
jug	NULL
DN	NULL
A	NULL
of	NULL
reporter	NULL
constructs	NULL
(	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
)	NULL
along	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
a	NULL
pLGP3-based	NULL
vector	NULL
expressing	NULL
full-length	NULL
murine	NULL
NF-ATp	NULL
(	NULL
NF-AT1I-C	NULL
;	NULL
reference	NULL
10	NULL
)	NULL
or	NULL
an	NULL
RSV-LTR	NULL
vector	NULL
expressing	NULL
human	NULL
NF-ATc	NULL
.	NULL

Human	NULL
293	NULL
embryonic	NULL
kidney	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
DMEM	NULL
and	NULL
transfected	NULL
using	NULL
a	NULL
calcium	NULL
phosphate	NULL
transfection	NULL
protocol	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
gene	NULL
construct	NULL
contains	NULL
the	NULL
wild-type	NULL
murine	NULL
CD25	NULL
promoter	NULL
spanning	NULL
the	NULL
nucleotides	NULL
up	NULL
to	NULL
position	NULL
-2556	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
one	NULL
or	NULL
both	NULL
of	NULL
the	NULL
NF-AT	NULL
p	NULL
binding	NULL
sites	NULL
around	NULL
positions	NULL
-585	NULL
and	NULL
-650	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
promoter	NULL
fragment	NULL
from	NULL
+1	NULL
to	NULL
-800	NULL
using	NULL
the	NULL
QuikChange	NULL
``	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
(	NULL
Stratagene	NULL
Corp.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
for	NULL
the	NULL
mutagenesis	NULL
of	NULL
NF-	NULL
AT	NULL
sites	NULL
:	NULL
)	NULL
(	NULL
667	NULL
)	NULL
GCTAGACTTAAAATCTATCATTGCAGCTGTAAACAC	NULL
(	NULL
-632	NULL
)	NULL
CGATCTGAATTTTAGATAGTAACGTCGACATTTGTG	NULL
;	NULL
and	NULL
(	NULL
)	NULL
(	NULL
-596	NULL
)	NULL
CCCACACCCATGATACTATGAATCGTGCATCAGAG	NULL
(	NULL
-562	NULL
)	NULL
GGGTGAGGGTACTATGATACTTAGCACGTAGTCTC	NULL
The	NULL
underlined	NULL
nucleotides	NULL
indicate	NULL
the	NULL
mutations	NULL
.	NULL

Immunofluorescenc	NULL
and	NULL
Flow	NULL
Cytometry	NULL
.	NULL

_	NULL
For	NULL
Ab	NULL
stainings	NULL
,	NULL
2-8	NULL
%	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
with	NULL
mAbs	NULL
at	NULL
saturating	NULL
concen-trations	NULL
.	NULL

Fluorescein-	NULL
and	NULL
PE-labeled	NULL
mAbs	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
used	NULL
for	NULL
two-	NULL
and	NULL
three-color	NULL
immunofluores	NULL
cence	NULL
.	NULL

For	NULL
three-color	NULL
flow	NULL
cytometry	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
first	NULL
with	NULL
biotinylated	NULL
mAbs	NULL
(	NULL
PharMingen	NULL
)	NULL
for	NULL
15	NULL
min	NULL
and	NULL
were	NULL
subsequently	NULL
incubated	NULL
with	NULL
streptavidin-R	NULL
ed	NULL
``	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Eg-genstein	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
FITC-	NULL
and	NULL
PE-labeled	NULL
mAbs	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Results	NULL
obtained	NULL
after	NULL
analysis	NULL
on	NULL
a	NULL
FACScan®	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
Lysys	NULL
II	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
are	NULL
shown	NULL
as	NULL
log	NULL
dot-plots	NULL
or	NULL
histograms	NULL
.	NULL

DN	NULL
ase	NULL
I	NULL
Footprint	NULL
Protection	NULL
Assays	NULL
and	NULL
EMSAs	NULL
.	NULL

In	NULL
DNase	NULL
I	NULL
footprint	NULL
protection	NULL
assays	NULL
,	NULL
end-labeled	NULL
DNA	NULL
probes	NULL
were	NULL
prepared	NULL
using	NULL
[	NULL
y-*PJATP	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

10¢	NULL
cpm	NULL
(	NULL
~0.2	NULL
ng	NULL
)	NULL
of	NULL
the	NULL
following	NULL
DNA	NULL
fragments	NULL
from	NULL
the	NULL
murine	NULL
CD25	NULL
promoter	NULL
(	NULL
4	NULL
)	NULL
were	NULL
used	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
HindIII-Sacll	NULL
fragment	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
position	NULL
+94	NULL
to	NULL
-268	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
the	NULL
Sacll-Bglll	NULL
fragment	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
-268	NULL
to	NULL
-801	NULL
.	NULL

Fragment	NULL
(	NULL
a	NULL
)	NULL
was	NULL
recut	NULL
with	NULL
Espl	NULL
,	NULL
and	NULL
fragment	NULL
(	NULL
6	NULL
)	NULL
with	NULL
Dral	NULL
generating	NULL
DNA	NULL
fragments	NULL
of	NULL
~150-300	NULL
bp	NULL
.	NULL

These	NULL
were	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
with	NULL
a	NULL
bacterially	NULL
expressed	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-NF-ATp	NULL
protein	NULL
(	NULL
11	NULL
)	NULL
containing	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
murine	NULL
NF-AT	NULL
p.	NULL
The	NULL
samples	NULL
were	NULL
processed	NULL
and	NULL
fractionated	NULL
on	NULL
6	NULL
%	NULL
polyacrylamide	NULL
,	NULL
42	NULL
%	NULL
urea-sequencing	NULL
gels	NULL
.	NULL

Electromobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
,	NULL
using	NULL
2	NULL
pg	NULL
nuclear	NULL
proteins	NULL
and	NULL
0.5	NULL
ug	NULL
poly	NULL
[	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
]	NULL
.	NULL

In	NULL
supershift	NULL
EMSAs	NULL
,	NULL
0.5	NULL
jg	NULL
of	NULL
either	NULL
an	NULL
NF-AT	NULL
p-specific	NULL
Ab	NULL
(	NULL
Cat	NULL
.	NULL

no	NULL
.	NULL

06-348	NULL
;	NULL
UBI	NULL
)	NULL
or	NULL
an	NULL
NF-ATe-specific	NULL
mAb	NULL
(	NULL
7A6	NULL
)	NULL
(	NULL
12	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
incubations	NULL
.	NULL

When	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
GST-NF-AT	NULL
p	NULL
was	NULL
tested	NULL
,	NULL
0.5-1.5	NULL
jg	NULL
of	NULL
bacterial	NULL
proteins	NULL
prepared	NULL
by	NULL
affinity	NULL
column	NULL
chromatography	NULL
(	NULL
11	NULL
)	NULL
were	NULL
incubated	NULL
along	NULL
with	NULL
0.5	NULL
ug	NULL
poly	NULL
[	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
]	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
:	NULL
1370	NULL
(	NULL
iii	NULL
)	NULL
(	NULL
-596	NULL
)	NULL
gateCCCACACCCATGGAACTATGAATCGTG	NULL
(	NULL
-571	NULL
)	NULL
GGGTGTGGGTACCTTGATACTTAGCAC.ctag	NULL
;	NULL
(	NULL
iv	NULL
)	NULL
(	NULL
-663	NULL
)	NULL
gatcGACTTAAAATCTTCCATTGCAGCTGTA	NULL
(	NULL
-635	NULL
)	NULL
CTGAATTTTAGAAGGTAACGTCGACATetag	NULL
;	NULL
and	NULL
(	NULL
v	NULL
)	NULL
(	NULL
-667	NULL
)	NULL
GCTAGACTTAAAATCTTCCATTGCAGCTGTAAACAC	NULL
(	NULL
-632	NULL
)	NULL
CGATCTGAATTTTAGAAGGTAACGTCGACATTTGTG	NULL
The	NULL
small	NULL
letters	NULL
indicate	NULL
linker	NULL
nucleotides	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
CD25	NULL
promoter	NULL
is	NULL
a	NULL
target	NULL
for	NULL
NF-AT	NULL
,	NULL
we	NULL
cotransfected	NULL
a	NULL
CD25	NULL
promoter-driven	NULL
luciferase	NULL
reporter	NULL
gene	NULL
with	NULL
NF-ATp-	NULL
and	NULL
NF-ATe-specific	NULL
expression	NULL
vectors	NULL
into	NULL
El4	NULL
T	NULL
and	NULL
293	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
293	NULL
cells	NULL
with	NULL
TPA	NULL
plus	NULL
ionomycin	NULL
(	NULL
T	NULL
+1	NULL
)	NULL
led	NULL
to	NULL
a	NULL
<	NULL
2-fold	NULL
,	NULL
and	NULL
treatment	NULL
of	NULL
E4	NULL
cells	NULL
with	NULL
T+Con	NULL
A	NULL
led	NULL
to	NULL
an	NULL
8-9-	NULL
fold	NULL
,	NULL
induction	NULL
of	NULL
activity	NULL
of	NULL
CD25	NULL
promoter	NULL
spanning	NULL
the	NULL
nucleotides	NULL
up	NULL
to	NULL
position	NULL
-2556	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
to	NULL
a	NULL
12-fold	NULL
induction	NULL
of	NULL
a	NULL
shorter	NULL
CD25	NULL
promoter	NULL
reaching	NULL
up	NULL
to	NULL
-800	NULL
.	NULL

Cotransfection	NULL
of	NULL
an	NULL
NF-ATp	NULL
expression	NULL
vector	NULL
into	NULL
El4	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
strong	NULL
,	NULL
40-fold	NULL
induction	NULL
of	NULL
activity	NULL
of	NULL
the	NULL
longer	NULL
CD25	NULL
promoter	NULL
and	NULL
in	NULL
an	NULL
up	NULL
to	NULL
60-fold	NULL
induction	NULL
of	NULL
the	NULL
shorter	NULL
CD25	NULL
promoter	NULL
fragment	NULL
after	NULL
T+Con	NULL
A	NULL
treatment	NULL
of	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Cotransfection	NULL
with	NULL
the	NULL
NF-ATe	NULL
vector	NULL
gave	NULL
rise	NULL
to	NULL
only	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
293	NULL
cells	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
both	NULL
NF-AT	NULL
factors	NULL
resulted	NULL
in	NULL
a	NULL
six-	NULL
to	NULL
ninefold	NULL
increase	NULL
in	NULL
CD25	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
binding	NULL
of	NULL
NF-ATp	NULL
to	NULL
the	NULL
CD25	NULL
promoter	NULL
,	NULL
GST-NF-ATp	NULL
encoding	NULL
its	NULL
DNA-binding	NULL
domain	NULL
was	NULL
incubated	NULL
with	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
first	NULL
800	NULL
bp	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
in	NULL
DNase	NULL
I	NULL
footprint	NULL
70	NULL
EL4	NULL
T	NULL
cells	NULL
293	NULL
cells	NULL
60	NULL
4	NULL
50	NULL
g	NULL
6	NULL
¥	NULL
40	NULL
,	NULL
3	NULL
k-I4	NULL
]	NULL
Ret	NULL
30	NULL
;	NULL
€	NULL
20	NULL
{	NULL
7	NULL
ﬁféQai	NULL
,	NULL
F	NULL
SASS	NULL
BPs	NULL
a	NULL
?	NULL

é	NULL
«	NULL
my	NULL
$	NULL
6	NULL
$	NULL
5	NULL
»	NULL
«	NULL
£35	NULL
?	NULL

6	NULL
«	NULL
``	NULL
«	NULL
«	NULL
&	NULL
Figure	NULL
1	NULL
.	NULL

NF-ATp	NULL
transactivates	NULL
the	NULL
murine	NULL
CD25	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
2.5	NULL
jug	NULL
DNA	NULL
of	NULL
luciferase	NULL
reporter	NULL
gene	NULL
constructs	NULL
controlled	NULL
by	NULL
murine	NULL
CD25	NULL
promoters	NULL
up	NULL
to	NULL
position	NULL
-2556	NULL
(	NULL
wt-2556	NULL
)	NULL
and	NULL
-800	NULL
(	NULL
wt-800	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
murine	NULL
E14	NULL
T	NULL
thymoma	NULL
cells	NULL
or	NULL
human	NULL
embryonic	NULL
293	NULL
kidney	NULL
cells	NULL
,	NULL
along	NULL
with	NULL
an	NULL
empty	NULL
R	NULL
SV-based	NULL
expression	NULL
vector	NULL
or	NULL
vectors	NULL
expressing	NULL
NF-ATp	NULL
(	NULL
10	NULL
)	NULL
or	NULL
NF-ATc	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
induced	NULL
as	NULL
indicated	NULL
for	NULL
18	NULL
h.	NULL
To	NULL
calculate	NULL
the	NULL
extent	NULL
of	NULL
induction	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CD25	NULL
wild-type	NULL
promoter	NULL
in	NULL
nonstimulated	NULL
cells	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
point	NULL
(	NULL
onefold	NULL
)	NULL
.	NULL

NF-	NULL
AT	NULL
Controls	NULL
the	NULL
CD25	NULL
Promoter	NULL
A	NULL
AaeTNF-AlP	NULL
eShget-NF-/	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
89	NULL
+-	NULL
B	NULL
ee	NULL
‘	NULL
Yu	NULL
Sgt	NULL
-600	NULL
«	NULL
-639+	NULL
i	NULL
wits	NULL
Whol	NULL
1	NULL
I	NULL
-686	NULL
»	NULL
aat	NULL
i	NULL
-577	NULL
-587	NULL
-637	NULL
-658	NULL
C	NULL
-639/-658	NULL
_	NULL
-577/-587	NULL
``	NULL
i	NULL
'	NULL
;	NULL
NS	NULL
«	NULL
008	NULL
e	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
NF-AT-DBD	NULL
wn	NULL
@	NULL
t	NULL
«	NULL
131415	NULL
Figure	NULL
2	NULL
.	NULL

Binding	NULL
of	NULL
NF-AT	NULL
to	NULL
the	NULL
CD25	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DNase	NULL
I	NULL
footprint	NULL
protection	NULL
as-say	NULL
.	NULL

A	NULL
CD25	NULL
promoter	NULL
probe	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
-548	NULL
to	NULL
-804	NULL
was	NULL
incubated	NULL
with	NULL
3	NULL
and	NULL
5	NULL
jg	NULL
BSA	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
1-5	NULL
ug	NULL
GST-NF-ATp	NULL
protein	NULL
(	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
p-specific	NULL
footprints	NULL
are	NULL
indicated	NULL
.	NULL

G	NULL
and	NULL
G+A	NULL
,	NULL
chemical	NULL
sequencing	NULL
reactions	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequences	NULL
of	NULL
footprint	NULL
regions	NULL
.	NULL

The	NULL
footprints	NULL
are	NULL
indicated	NULL
in	NULL
brackets	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
direction	NULL
of	NULL
TGGAA	NULL
NF-AT	NULL
``	NULL
core	NULL
``	NULL
motifs	NULL
.	NULL

The	NULL
TPA	NULL
responsive	NULL
element-like	NULL
sequence	NULL
motifs	NULL
3	NULL
``	NULL
from	NULL
the	NULL
NF-AT	NULL
motifs	NULL
are	NULL
boxed	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSAs	NULL
with	NULL
the	NULL
NF-AT	NULL
sites	NULL
.	NULL

In	NULL
lanes	NULL
/-/2	NULL
,	NULL
nuclear	NULL
proteins	NULL
from	NULL
murine	NULL
splenocytes	NULL
are	NULL
shown	NULL
,	NULL
and	NULL
in	NULL
lanes	NULL
2	NULL
©	NULL
it	NULL
_	NULL
-729	NULL
>	NULL
z	NULL
B	NULL
l	NULL
--	NULL
--	NULL
.-_-_	NULL
--	NULL
.	NULL

mene	NULL
ose	NULL
ors	NULL
-	NULL
GeT	NULL
AGA	NULL
CTT	NULL
An	NULL
Te	NULL
ca	NULL
(	NULL
-667	NULL
)	NULL
aa	NULL
ATC	NULL
T	NULL
T	NULL
TGC	NULL
AGC	NULL
NF-AT4	NULL
(	NULL
?	NULL
)	NULL

C	NULL
Wi	NULL
NF-ATp+c	NULL
[	NULL
WB	NULL
<	NULL
--	NULL
-	NULL
o	NULL
--	NULL
(	NULL
-sgeCCC	NULL
Aca	NULL
coc	NULL
arto	NULL
cam	NULL
cta	NULL
Toa	NULL
ATC	NULL
ero	NULL
cat	NULL
cag	NULL
Ac	NULL
ACT	NULL
TAG	NULL
CAC	NULL
GTA	NULL
GTC	NULL
Tc	NULL
GGG	NULL
TGA	NULL
GGG	NULL
TAC	NULL
CTT	NULL
GAT	NULL
finn	NULL
>	NULL
--	NULL
.	NULL

>	NULL
--	NULL
-	NULL
~-	NULL
+	NULL
--	NULL
omaiiness	NULL
of	NULL
AT	NULL
site	NULL
as	NULL
indicated	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
autoradiograph	NULL
of	NULL
lanes	NULL
1-6	NULL
was	NULL
exposed	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011121314151617	NULL
181920	NULL
}	NULL
TGT	NULL
aaa	NULL
CAC	NULL
conan	NULL
|Tect	NULL
car	NULL
Trt	NULL
tac	NULL
aac	NULL
ora	NULL
aco	NULL
TcG	NULL
acA	NULL
TPF	NULL
are	NULL
(	NULL
822	NULL
)	NULL
13-15	NULL
,	NULL
GST-NF-ATp	NULL
was	NULL
used	NULL
with	NULL
the	NULL
-639/	NULL
-658	NULL
(	NULL
lanes	NULL
1-6	NULL
and	NULL
13	NULL
)	NULL
and	NULL
-577/	NULL
-587	NULL
probes	NULL
(	NULL
lanes	NULL
7-12	NULL
and	NULL
15	NULL
)	NULL
.	NULL

In	NULL
lane	NULL
14	NULL
,	NULL
a	NULL
probe	NULL
of	NULL
the	NULL
-610/-636	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

2	NULL
jg	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
unin-duced	NULL
splenocytes	NULL
(	NULL
-	NULL
)	NULL
or	NULL
splenocytes	NULL
induced	NULL
for	NULL
2	NULL
h	NULL
with	NULL
T+I	NULL
(	NULL
+	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
0.5	NULL
ug	NULL
NF-ATc-	NULL
or	NULL
NF-AT	NULL
p-specific	NULL
Abs	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
homologous	NULL
unlabeled	NULL
probes	NULL
or	NULL
distal	NULL
IL-2	NULL
NF-for	NULL
16	NULL
h	NULL
,	NULL
and	NULL
that	NULL
of	NULL
lanes	NULL
7-12	NULL
for	NULL
3	NULL
d.	NULL
NS	NULL
,	NULL
nonspecific	NULL
complex	NULL
.	NULL

Free	NULL
(	NULL
-562	NULL
)	NULL
probes	NULL
are	NULL
cut	NULL
off	NULL
.	NULL

(	NULL
D	NULL
)	NULL
EMSAs	NULL
of	NULL
the	NULL
-639/	NULL
-658	NULL
site	NULL
using	NULL
nuclear	NULL
proteins	NULL
from	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
probe	NULL
of	NULL
the	NULL
-639/	NULL
-658	NULL
site	NULL
was	NULL
incubated	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
T+I	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
100	NULL
ng/ml	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
the	NULL
following	NULL
DN	NULL
As	NULL
were	NULL
used	NULL
:	NULL
5-50	NULL
ng	NULL
of	NULL
the	NULL
cold	NULL
-639/	NULL
-658	NULL
site	NULL
and	NULL
the	NULL
distal	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
,	NULL
or	NULL
10	NULL
and	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
proximal	NULL
IL-2	NULL
octamer	NULL
site	NULL
(	NULL
11	NULL
)	NULL
and	NULL
a	NULL
consensus	NULL
AP-1	NULL
site	NULL
.	NULL

In	NULL
lanes	NULL
16	NULL
and	NULL
77	NULL
,	NULL
0.5	NULL
g	NULL
of	NULL
NF-AT-specific	NULL
Abs	NULL
were	NULL
added	NULL
.	NULL

In	NULL
lanes	NULL
18-20	NULL
,	NULL
a	NULL
-632/	NULL
-667	NULL
probe	NULL
mutated	NULL
in	NULL
the	NULL
NF-AT	NULL
site	NULL
(	NULL
see	NULL
oligonucleotide	NULL
a	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
was	NULL
incubated	NULL
without	NULL
or	NULL
with	NULL
NF-AT-specific	NULL
Abs	NULL
.	NULL

protection	NULL
assays	NULL
.	NULL

Two	NULL
prominent	NULL
footprints	NULL
were	NULL
de-tected	NULL
,	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
-577	NULL
to	NULL
-587	NULL
and	NULL
-639	NULL
to	NULL
-658	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

These	NULL
comprise	NULL
the	NULL
NF-AT	NULL
``	NULL
core	NULL
``	NULL
binding	NULL
sequence	NULL
TGGAA	NULL
(	NULL
7	NULL
)	NULL
in	NULL
opposite	NULL
orientations	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

When	NULL
probes	NULL
of	NULL
these	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
with	NULL
GST-NF-ATp	NULL
in	NULL
EMSAs	NULL
,	NULL
both	NULL
probes	NULL
were	NULL
bound	NULL
by	NULL
NF-ATp	NULL
,	NULL
whereas	NULL
a	NULL
third	NULL
probe	NULL
spanning	NULL
the	NULL
unprotected	NULL
nucleotides	NULL
from	NULL
-619	NULL
to	NULL
-636	NULL
was	NULL
unable	NULL
to	NULL
bind	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
lanes	NULL
13-15	NULL
)	NULL
.	NULL

U	NULL
sing	NULL
nuclear	NULL
proteins	NULL
from	NULL
murine	NULL
splenocytes	NULL
,	NULL
the	NULL
generation	NULL
of	NULL
typical	NULL
inducible	NULL
NF-AT	NULL
complexes	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
-639/	NULL
-658	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
lanes	NULL
1-6	NULL
)	NULL
and	NULL
,	NULL
although	NULL
far	NULL
more	NULL
weakly	NULL
,	NULL
with	NULL
the	NULL
-577/-587	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
lanes	NULL
7-72	NULL
)	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
enhanced	NULL
after	NULL
induction	NULL
of	NULL
cells	NULL
with	NULL
T+I	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
and	NULL
efficiently	NULL
competed	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
dis	NULL
tal	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
complexes	NULL
were	NULL
supershifted	NULL
in	NULL
EMSAs	NULL
using	NULL
NFAT	NULL
p-	NULL
and	NULL
NF-	NULL
AT	NULL
e-specific	NULL
Abs	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
-639/	NULL
-658	NULL
site	NULL
corresponds	NULL
to	NULL
a	NULL
high-affinity	NULL
NFAT	NULL
binding	NULL
site	NULL
.	NULL

This	NULL
could	NULL
be	NULL
seen	NULL
best	NULL
in	NULL
EMSA	NULL
compe-	NULL
1371	NULL
Schuh	NULL
et	NULL
al	NULL
.	NULL

tition	NULL
assays	NULL
comparing	NULL
the	NULL
binding	NULL
of	NULL
NF-AT	NULL
factors	NULL
in	NULL
nuclear	NULL
protein	NULL
preparations	NULL
from	NULL
T	NULL
+I-induced	NULL
Jurkat	NULL
cells	NULL
to	NULL
this	NULL
site	NULL
and	NULL
the	NULL
distal	NULL
NF-AT	NULL
site	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

Although	NULL
5-10	NULL
ng	NULL
of	NULL
the	NULL
-639/	NULL
-658	NULL
site	NULL
was	NULL
sufficient	NULL
to	NULL
suppress	NULL
almost	NULL
all	NULL
NF-AT	NULL
binding	NULL
,	NULL
10-50	NULL
ng	NULL
of	NULL
the	NULL
distal	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
was	NULL
necessary	NULL
to	NULL
see	NULL
the	NULL
same	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
,	NULL
lanes	NULL
6-11	NULL
)	NULL
.	NULL

50	NULL
ng	NULL
of	NULL
an	NULL
AP-1	NULL
site	NULL
was	NULL
also	NULL
able	NULL
to	NULL
suppress	NULL
NF-AT	NULL
complex	NULL
formation	NULL
,	NULL
whereas	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
the	NULL
upstream	NULL
promoter	NULL
site	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
an	NULL
efficient	NULL
octamer	NULL
but	NULL
poor	NULL
AP-1	NULL
site	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
11	NULL
)	NULL
,	NULL
was	NULL
without	NULL
effect	NULL
on	NULL
factor	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
,	NULL
lanes	NULL
12-15	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
-639/	NULL
-658	NULL
site	NULL
,	NULL
the	NULL
-577/	NULL
-5§87	NULL
NF-	NULL
AT	NULL
p	NULL
binding	NULL
site	NULL
is	NULL
a	NULL
low-affinity	NULL
NF-	NULL
AT	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
lanes	NULL
7-12	NULL
;	NULL
note	NULL
that	NULL
lanes	NULL
7-12	NULL
were	NULL
exposed	NULL
five	NULL
times	NULL
longer	NULL
than	NULL
lanes	NULL
7-6	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
the	NULL
two	NULL
NF-ATp	NULL
sites	NULL
,	NULL
we	NULL
introduced	NULL
mutations	NULL
into	NULL
the	NULL
NF-AT	NULL
motifs	NULL
of	NULL
each	NULL
site	NULL
,	NULL
or	NULL
into	NULL
both	NULL
sites	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
800-bp	NULL
wild-type	NULL
CD25	NULL
promoter	NULL
fragment	NULL
.	NULL

These	NULL
mutations	NULL
led	NULL
to	NULL
a	NULL
loss	NULL
of	NULL
NF-AT	NULL
binding	NULL
in	NULL
EMSAs	NULL
using	NULL
nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
Jurkat	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
,	NULL
lanes	NULL
18-20	NULL
)	NULL
Brief	NULL
Definitive	NULL
R	NULL
eport	NULL
ud	NULL
fold	NULL
induction	NULL
fold	NULL
induction	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
The	NULL
NF-AT	NULL
p	NULL
sites	NULL
contribute	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
CD25	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Mutations	NULL
within	NULL
the	NULL
NF-	NULL
AT	NULL
p	NULL
sites	NULL
that	NULL
suppress	NULL
NF-AT	NULL
binding	NULL
interfere	NULL
with	NULL
the	NULL
T+Con	NULL
A-mediated	NULL
CD25	NULL
promoter	NULL
induction	NULL
in	NULL
El4	NULL
cells	NULL
.	NULL

2.5	NULL
g	NULL
of	NULL
luciferase	NULL
constructs	NULL
containing	NULL
the	NULL
wild-type	NULL
CD25	NULL
promoter	NULL
up	NULL
to	NULL
-800	NULL
bp	NULL
or	NULL
a	NULL
promoter	NULL
with	NULL
mutations	NULL
in	NULL
the	NULL
-658/	NULL
-639	NULL
(	NULL
mut	NULL
.	NULL

1	NULL
)	NULL
,	NULL
the	NULL
-587/	NULL
-577	NULL
site	NULL
(	NULL
mut	NULL
.	NULL

2	NULL
)	NULL
,	NULL
or	NULL
in	NULL
both	NULL
sites	NULL
(	NULL
mut	NULL
.	NULL

1+2	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
E4	NULL
cells	NULL
that	NULL
were	NULL
induced	NULL
for	NULL
12	NULL
h.	NULL
(	NULL
B	NULL
)	NULL
Mutations	NULL
of	NULL
NF-AT	NULL
sites	NULL
suppress	NULL
the	NULL
NF-AT	NULL
p-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
CD25	NULL
promoter	NULL
.	NULL

0.5	NULL
jug	NULL
of	NULL
the	NULL
CD25	NULL
luciferase	NULL
constructs	NULL
was	NULL
cotransfected	NULL
with	NULL
an	NULL
NF-ATp	NULL
expression	NULL
vector	NULL
into	NULL
El4	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
for	NULL
12	NULL
h.	NULL
To	NULL
calculate	NULL
the	NULL
extent	NULL
of	NULL
induction	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CD25	NULL
wild-type	NULL
promoter	NULL
in	NULL
nonstimulated	NULL
cells	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
point	NULL
(	NULL
onefold	NULL
)	NULL
.	NULL

or	NULL
GST-NF-ATp	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
mutated	NULL
CD25	NULL
promoter/	NULL
luciferase	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
E4	NULL
T	NULL
cells	NULL
alone	NULL
or	NULL
with	NULL
an	NULL
NF-ATp	NULL
expression	NULL
vector	NULL
their	NULL
induction	NULL
was	NULL
severely	NULL
impaired	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
promoter	NULL
.	NULL

The	NULL
T+Con	NULL
A-mediated	NULL
16-fold	NULL
induction	NULL
of	NULL
the	NULL
800-bp	NULL
CD25	NULL
promoter	NULL
fragment	NULL
was	NULL
almost	NULL
abolished	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
and	NULL
its	NULL
>	NULL
25-fold	NULL
transactivation	NULL
by	NULL
NF-ATp	NULL
was	NULL
reduced	NULL
to	NULL
a	NULL
2-3-fold	NULL
increase	NULL
for	NULL
the	NULL
mutated	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
NF-	NULL
AT	NULL
p	NULL
sites	NULL
for	NULL
the	NULL
CD25	NULL
expression	NULL
is	NULL
underlined	NULL
by	NULL
defects	NULL
in	NULL
the	NULL
CD25	NULL
surface	NULL
expression	NULL
on	NULL
LN	NULL
T	NULL
cells	NULL
fom	NULL
NF-ATp-'-	NULL
mice	NULL
established	NULL
in	NULL
our	NULL
laboratory	NULL
(	NULL
13	NULL
)	NULL
.	NULL

When	NULL
LN	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
mice	NULL
were	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
«	NULL
-CD3	NULL
Abs	NULL
for	NULL
2-24	NULL
h	NULL
in	NULL
vitro	NULL
,	NULL
a	NULL
marked	NULL
increase	NULL
of	NULL
CD25	NULL
surface	NULL
expression	NULL
was	NULL
detected	NULL
after	NULL
6-12	NULL
h	NULL
,	NULL
which	NULL
became	NULL
even	NULL
more	NULL
pronounced	NULL
after	NULL
24	NULL
h.	NULL
Due	NULL
to	NULL
the	NULL
strong	NULL
stimulation	NULL
of	NULL
the	NULL
CD25	NULL
promoter	NULL
by	NULL
secreted	NULL
IL-2	NULL
(	NULL
2	NULL
)	NULL
,	NULL
>	NULL
50	NULL
%	NULL
of	NULL
T	NULL
cells	NULL
express	NULL
large	NULL
amounts	NULL
of	NULL
CD25	NULL
48	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

On	NULL
NF-ATp-	NULL
-	NULL
LN	NULL
T	NULL
cells	NULL
,	NULL
CD25	NULL
expression	NULL
was	NULL
found	NULL
to	NULL
be	NULL
distinctly	NULL
delayed	NULL
,	NULL
becoming	NULL
clearly	NULL
detectable	NULL
only	NULL
24	NULL
h	NULL
after	NULL
induction	NULL
in	NULL
spite	NULL
of	NULL
high	NULL
,	NULL
unimpaired	NULL
IL-2	NULL
production	NULL
of	NULL
NF-ATp-'-	NULL
T	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
fewer	NULL
cells	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
CD25	NULL
after	NULL
induction	NULL
for	NULL
48	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
two	NULL
NF-ATp	NULL
binding	NULL
sites	NULL
are	NULL
located	NULL
near	NULL
the	NULL
CD25	NULL
promoter	NULL
and	NULL
therefore	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
rapid	NULL
induction	NULL
of	NULL
the	NULL
murine	NULL
CD25	NULL
gene	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
The	NULL
core	NULL
sequences	NULL
of	NULL
these	NULL
sites	NULL
TGGAA	NULL
,	NULL
differ	NULL
slightly	NULL
from	NULL
the	NULL
AGGAAAA	NULL
core	NULL
motifs	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
and	NULL
are	NULL
the	NULL
strongest	NULL
NF-	NULL
AT	NULL
p	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
GM-CSF	NULL
enhancer	NULL
(	NULL
14	NULL
)	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
7-9	NULL
bp	NULL
3	NULL
'	NULL
to	NULL
the	NULL
NF-AT	NULL
motifs	NULL
are	NULL
situated	NULL
TPA-responsive	NULL
element-like	NULL
sequences	NULL
that	NULL
might	NULL
allow	NULL
the	NULL
con	NULL
1372	NULL
certed	NULL
binding	NULL
of	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
.	NULL

In	NULL
EMSAs	NULL
we	NULL
detected	NULL
a	NULL
specific	NULL
binding	NULL
of	NULL
GST-c-Jun	NULL
to	NULL
both	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
shown	NULL
which	NULL
proteins	NULL
of	NULL
the	NULL
AP-	NULL
1	NULL
family	NULL
bind	NULL
and	NULL
regulate	NULL
the	NULL
CD25	NULL
promoter	NULL
in	NULL
vivo	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
should	NULL
be	NULL
pointed	NULL
out	NULL
that	NULL
several	NULL
properties	NULL
of	NULL
NF-ATp-~'~-	NULL
mice	NULL
,	NULL
such	NULL
as	NULL
the	NULL
impaired	NULL
clonal	NULL
deletion	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
expansion	NULL
of	NULL
lymphoid	NULL
organs	NULL
(	NULL
13	NULL
,	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
are	NULL
shared	NULL
by	NULL
the	NULL
mice	NULL
deficient	NULL
for	NULL
IL-2	NULL
and	NULL
IL-2	NULL
receptors	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

We	NULL
assume	NULL
that	NULL
the	NULL
impaired	NULL
CD25	NULL
expression	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
this	NULL
phenotype	NULL
in	NULL
NF-ATp-~	NULL
~	NULL
mice	NULL
,	NULL
which	NULL
is	NULL
reminiscent	NULL
of	NULL
other	NULL
mice	NULL
with	NULL
defects	NULL
in	NULL
the	NULL
IL-2	NULL
signaling	NULL
system	NULL
.	NULL

Figure	NULL
4	NULL
.	NULL

Impaired	NULL
CD25	NULL
expres	NULL
sion	NULL
on	NULL
NF-ATp~~	NULL
LN	NULL
T	NULL
cells	NULL
.	NULL

LN	NULL
T	NULL
cells	NULL
from	NULL
NF-ATp*'*	NULL
and	NULL
NF-ATp~'~	NULL
mice	NULL
(	NULL
13	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
plate-bound	NULL
«	NULL
-CD3	NULL
mAb	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
mAbs	NULL
Tha	NULL
...	NULL
|	NULL
directed	NULL
against	NULL
murine	NULL
CD25	NULL
(	NULL
7D4	NULL
;	NULL
r	NULL
a	NULL
PharMingen	NULL
)	NULL
and	NULL
«	NULL
/B-TCR	NULL
(	NULL
H57-597	NULL
;	NULL
PharMingen	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CD25	NULL
on	NULL
«	NULL
/	NULL
B-TCR	NULL
*	NULL
LN	NULL
cells	NULL
is	NULL
60	NULL
NF-ATpH+	NULL
1	NULL
shown	NULL
.	NULL

The	NULL
lowest	NULL
panel	NULL
shows	NULL
a	NULL
w	NULL
40	NULL
comparison	NULL
of	NULL
CD25	NULL
expression	NULL
on	NULL
§	NULL
20	NULL
NF-ATp**	NULL
_	NULL
and	NULL
-	NULL
NF-ATp~'-8	NULL
o	NULL
k	NULL
TCR	NULL
+	NULL
LN	NULL
cells	NULL
stimulated	NULL
for	NULL
24	NULL
h.	NULL
10	NULL
100	NULL
ao	NULL
ao	NULL
ao	NULL
CD25-FITC	NULL
-	NULL
»	NULL
The	NULL
dotted	NULL
line	NULL
indicates	NULL
the	NULL
isotype	NULL
control	NULL
staining	NULL
of	NULL
LN	NULL
cells	NULL
.	NULL

NF-	NULL
AT	NULL
Controls	NULL
the	NULL
CD25	NULL
Promoter	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
Daniela	NULL
R	NULL
ith	NULL
and	NULL
Heidi	NULL
R	NULL
unknagel	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
wish	NULL
to	NULL
thank	NULL
Dr.	NULL
M.	NULL
Nabholz	NULL
(	NULL
Swiss	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
)	NULL
and	NULL
Dr.	NULL
A.	NULL
R	NULL
ao	NULL
(	NULL
Center	NULL
for	NULL
Blood	NULL
R	NULL
esearch	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
DNA	NULL
constructs	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Wilhelm-Sander-Stiftung	NULL
(	NULL
to	NULL
E.	NULL
Serfling	NULL
)	NULL
and	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
,	NULL
SFBs	NULL
165	NULL
and	NULL
465	NULL
(	NULL
to	NULL
A.	NULL
Schimpl	NULL
and	NULL
E.	NULL
Serfling	NULL
)	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Edgar	NULL
Serfling	NULL
,	NULL
Department	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Wiirzburg	NULL
,	NULL
Josef-Schneider-Str	NULL
.	NULL

2	NULL
,	NULL
D-97080	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
.	NULL

Phone	NULL
:	NULL
49-931-201-34-29/	NULL
95	NULL
;	NULL
Fax	NULL
:	NULL
49-931-201-34-40	NULL
;	NULL
E-mail	NULL
:	NULL
pathO15	NULL
@	NULL
mail.uni-	NULL
wuerzburg	NULL
.	NULL

de	NULL
Received	NULL
for	NULL
publication	NULL
27	NULL
January	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
29	NULL
July	NULL
1998	NULL
.	NULL

References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

Minami	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Kono	NULL
,	NULL
T.	NULL
Miyazaki	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
IL-2	NULL
receptor	NULL
complex	NULL
:	NULL
its	NULL
structure	NULL
,	NULL
function	NULL
,	NULL
and	NULL
target	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:245-268.	NULL
.	NULL

Sperisen	NULL
,	NULL
P.	NULL
,	NULL
SM	NULL
.	NULL

Wang	NULL
,	NULL
E.	NULL
Soldaini	NULL
,	NULL
M.	NULL
Pla	NULL
,	NULL
C.	NULL
R	NULL
usterholz	NULL
,	NULL
P.	NULL
Bucher	NULL
,	NULL
P.	NULL
Corthesy	NULL
,	NULL
P.	NULL
Reichenbach	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1995	NULL
.	NULL

Mouse	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
gene	NULL
expression	NULL
.	NULL

In-terleukin-1	NULL
and	NULL
interleukin-2	NULL
control	NULL
transcription	NULL
via	NULL
dis	NULL
tinct	NULL
cis-acting	NULL
elements	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

277:10743-10752.	NULL
.	NULL

John	NULL
,	NULL
S.	NULL
,	NULL
R.B	NULL
.	NULL

Reeves	NULL
,	NULL
J.-Y	NULL
.	NULL

Lin	NULL
,	NULL
R.	NULL
Child	NULL
,	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
C.B	NULL
.	NULL

Thompson	NULL
,	NULL
and	NULL
W.J	NULL
.	NULL

Leonard	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
cell-type-specific	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
gene	NULL
ex-pression	NULL
:	NULL
potential	NULL
role	NULL
of	NULL
physical	NULL
interactions	NULL
between	NULL
EIf	NULL
1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
NF-kB	NULL
family	NULL
proteins	NULL
Mol	NULL
.	NULL

Céll	NULL
.	NULL

Biol	NULL
15	NULL
:	NULL
1786-1796.	NULL
.	NULL

Serdobova	NULL
,	NULL
I.	NULL
,	NULL
M.	NULL
Pla	NULL
,	NULL
P.	NULL
Reichenbach	NULL
,	NULL
P.	NULL
Sperisen	NULL
,	NULL
J.	NULL
Ghys	NULL
dael	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
J.	NULL
Freeman	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1997	NULL
.	NULL

Elf	NULL
1	NULL
contributes	NULL
to	NULL
the	NULL
function	NULL
of	NULL
the	NULL
complex	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2-responsive	NULL
enhancer	NULL
in	NULL
mouse	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1211-1221.	NULL
.	NULL

John	NULL
,	NULL
S.	NULL
,	NULL
C.M	NULL
.	NULL

Robbins	NULL
,	NULL
and	NULL
W.J	NULL
.	NULL

Leonard	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
IL-2	NULL
response	NULL
element	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
promoter	NULL
is	NULL
a	NULL
composite	NULL
element	NULL
that	NULL
binds	NULL
Stat5	NULL
,	NULL
EIf	NULL
1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
and	NULL
a	NULL
GATA	NULL
family	NULL
protein	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Or-gon	NULL
.	NULL
)	NULL

J	NULL
.	NULL

15:5627-5635.	NULL
.	NULL

Lecine	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Algarte	NULL
,	NULL
P.	NULL
Rameil	NULL
,	NULL
C.	NULL
Beadling	NULL
,	NULL
P.	NULL
Bucher	NULL
,	NULL
M.	NULL
Nabholz	NULL
,	NULL
and	NULL
J.	NULL
Imbert	NULL
.	NULL

1996	NULL
.	NULL

Elf-1	NULL
and	NULL
Stat5	NULL
bind	NULL
to	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
a	NULL
new	NULL
enhancer	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:6829-6840.	NULL
.	NULL

Rao	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
and	NULL
P.G	NULL
.	NULL

Hogan	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
fac-	NULL
tors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
:	NULL
regulation	NULL
and	NULL
function	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:707-747.	NULL
.	NULL

Wolf	NULL
,	NULL
S.A.	NULL
,	NULL
P.	NULL
Zhou	NULL
,	NULL
V.	NULL
Détsch	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
A	NULL
.	NULL

You	NULL
,	NULL
S.N	NULL
.	NULL

Ho	NULL
,	NULL
G.R	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
Wagner	NULL
,	NULL
and	NULL
G.L	NULL
.	NULL

Verdine	NULL
.	NULL

1997	NULL
.	NULL

Unusual	NULL
Rel-like	NULL
architecture	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-ATc	NULL
.	NULL

Nature	NULL
385:172-176.	NULL
.	NULL

Gauchat	NULL
,	NULL
J.-F.	NULL
,	NULL
EW	NULL
.	NULL

Khandjian	NULL
,	NULL
and	NULL
R.	NULL
Weil	NULL
.	NULL

1986	NULL
.	NULL

Cy-	NULL
closporin	NULL
A	NULL
prevents	NULL
induction	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
in	NULL
cultured	NULL
murine	NULL
thymocytes	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sd	NULL
.	NULL

USA	NULL
.	NULL

83:6430-6434	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
J.A	NULL
.	NULL

Carew	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
T.M	NULL
.	NULL

Badalian	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
P.G	NULL
.	NULL

Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Re-combinant	NULL
NFAT	NULL
1	NULL
(	NULL
NFAT	NULL
p	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
1373	NULL
Schuh	NULL
et	NULL
al	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19.	NULL
cells	NULL
and	NULL
mediates	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:3955-3966	NULL
.	NULL

Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
S.	NULL
Klein-Hessling	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
S.	NULL
Chuvpilo	NULL
,	NULL
C.	NULL
Escher	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
B.	NULL
Hentsch	NULL
,	NULL
H.	NULL
Schwarzenbach	NULL
,	NULL
P.	NULL
Mat-thias	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1994	NULL
.	NULL

Octamer	NULL
factors	NULL
exert	NULL
a	NULL
dual	NULL
effect	NULL
on	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

153:5572-5585	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
SN	NULL
.	NULL

Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.J	NULL
.	NULL

Thomas	NULL
,	NULL
L.A.	NULL
Tim-merman	NULL
,	NULL
G.P	NULL
.	NULL

Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
.	NULL

369:497-502	NULL
.	NULL

Schuh	NULL
,	NULL
K.	NULL
,	NULL
B.	NULL
Kneitz	NULL
,	NULL
J.	NULL
Heyer	NULL
,	NULL
F.	NULL
Siebelt	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
E.	NULL
Jan-kevics	NULL
,	NULL
E.	NULL
Riide	NULL
,	NULL
E.	NULL
Schmitt	NULL
,	NULL
A.	NULL
Schimpl	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1997	NULL
.	NULL

NF-ATp	NULL
plays	NULL
a	NULL
prominent	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
Th2-type	NULL
lymphokines	NULL
.	NULL

Immuno	NULL
.	NULL

Lat	NULL
.	NULL

57:171-175	NULL
.	NULL

Cockerill	NULL
,	NULL
P.N	NULL
.	NULL

,	NULL
A.G.	NULL
Bert	NULL
,	NULL
F.	NULL
Jenkins	NULL
,	NULL
G.R	NULL
.	NULL

R	NULL
yan	NULL
,	NULL
M.F	NULL
.	NULL

Shan-non	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
1995	NULL
.	NULL

Human	NULL
granulocyte-macro-phage	NULL
colony-stimulating	NULL
factor	NULL
enhancer	NULL
function	NULL
is	NULL
associated	NULL
with	NULL
cooperative	NULL
interactions	NULL
between	NULL
AP-1	NULL
and	NULL
NFAT	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2071-2079	NULL
.	NULL

Hodge	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
A.M.	NULL
Ranger	NULL
,	NULL
F.C	NULL
.	NULL

de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
M.J.	NULL
Grusby	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Hyperproliferation	NULL
and	NULL
dysregulation	NULL
of	NULL
IL-4	NULL
expression	NULL
in	NULL
NF-ATp-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
.	NULL

4:397-405	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.P.B	NULL
.	NULL

Viola	NULL
,	NULL
K.T.Y	NULL
.	NULL

Shaw	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.D	NULL
.	NULL

Wallace	NULL
,	NULL
P.T	NULL
.	NULL

Bozza	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
enhanced	NULL
immune	NULL
response	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT	NULL
1	NULL
.	NULL

Sdene	NULL
.	NULL

272:892-895	NULL
.	NULL

Kneitz	NULL
,	NULL
B.	NULL
,	NULL
T.	NULL
Herrmann	NULL
,	NULL
S.	NULL
Yonehara	NULL
,	NULL
and	NULL
A.	NULL
Schimpl	NULL
.	NULL

1995	NULL
.	NULL

Normal	NULL
clonal	NULL
expansion	NULL
but	NULL
impaired	NULL
Fas	NULL
mediated	NULL
cell	NULL
death	NULL
and	NULL
anergy	NULL
induction	NULL
in	NULL
interleukin-2-deficient	NULL
mice	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:2572-2577	NULL
.	NULL

Willerford	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
J.	NULL
Chen	NULL
,	NULL
J.A	NULL
.	NULL

Ferry	NULL
,	NULL
L.	NULL
Davidson	NULL
,	NULL
A.	NULL
Ma	NULL
,	NULL
and	NULL
FW	NULL
.	NULL

Alt	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
regulates	NULL
the	NULL
size	NULL
and	NULL
content	NULL
of	NULL
the	NULL
peripheral	NULL
lymphoid	NULL
compart-ment	NULL
.	NULL

Immunity	NULL
.	NULL

3:521-530	NULL
.	NULL

Suzuki	NULL
,	NULL
H.	NULL
,	NULL
TM	NULL
.	NULL

Kiindig	NULL
,	NULL
C.	NULL
Furlonger	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
E.	NULL
Timms	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
R.	NULL
Schmits	NULL
,	NULL
J.L	NULL
.	NULL

Simard	NULL
,	NULL
P.S	NULL
.	NULL

Ohashi	NULL
,	NULL
H.	NULL
Griesser	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Deregulated	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
au-toimmunity	NULL
in	NULL
mice	NULL
lacking	NULL
interleukin-2	NULL
receptor	NULL
B.	NULL
Saene	NULL
.	NULL

268:1472-1476	NULL
.	NULL

Brief	NULL
Definitive	NULL
R	NULL
eport	NULL

